Blood products group CSL has reported a net profit of $US1.2 billion, an increase of 19%

CommSec

Online Stockbroker

Blood products group CSL has reported a net profit of $US1.2 billion, an increase of 19%. The group announced a final dividend of was US52c which was in line with estimates. Capital management was amongst the positive factors. With the current share buy almost complete, CSL is considering returning more capital to investors. The outlook for earnings growth was as expected, with a profit forecast to grow by 10% in 2014. CSL will pay an unfranked final dividend of US 52 cents on the 4th of October. The total annual dividend of $US1.02 is an 18 per cent increase compared to the previous year. For more information visit investing.commsec.com.au/reportingseason


CommSec
CommSec
Online Stockbroker
Online Stockbroker

CommSec is Australia's leading online broker. CommSec has been committed to providing the best in online trading since 1995. CommSec helps make informed investment decisions with comprehensive market research, free live pricing and powerful...

Expertise

No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.